Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.055
-0.025 (-0.81%)
Apr 9, 2026, 2:04 PM EDT - Market open
Exagen Employees
As of December 31, 2025, Exagen had 220 total employees, including 216 full-time and 4 part-time employees. The number of employees increased by 5 or 2.33% compared to the previous year.
Employees
220
Change (1Y)
5
Growth (1Y)
2.33%
Revenue / Employee
$302,614
Profits / Employee
-$90,686
Market Cap
73.48M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 220 | 5 | 2.33% | 216 | 4 |
| Dec 31, 2024 | 215 | 36 | 20.11% | 209 | 6 |
| Dec 31, 2023 | 179 | -25 | -12.25% | 174 | 5 |
| Dec 31, 2022 | 204 | -18 | -8.11% | 199 | 5 |
| Dec 31, 2021 | 222 | 39 | 21.31% | 219 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| Fulgent Genetics | 1,315 |
| Burning Rock Biotech | 674 |
| FONAR | 535 |
| Biodesix | 334 |
| MDxHealth | 312 |
| Prenetics Global | 285 |
| Precipio | 60 |
XGN News
- 4 weeks ago - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results - GlobeNewsWire
- 5 weeks ago - Exagen Inc. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewsWire
- 3 months ago - Exagen Inc. Announces Select Preliminary 2025 Financial Results - GlobeNewsWire
- 5 months ago - Exagen Inc. to Participate in Fourth Quarter Investor Conferences - GlobeNewsWire
- 5 months ago - Exagen Inc. Reports Strong Q3 2025 Results - GlobeNewsWire
- 6 months ago - Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence - GlobeNewsWire
- 6 months ago - Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire